Converge Bio Receives $2.5 Million Gates Foundation Grant to Apply AI to Crop Genomics

June 02, 2026
Converge Bio has secured a $2.5 million grant from the Gates Foundation to expand its AI gene discovery platform from pharmaceuticals to crop genomics, aiming to improve agricultural resilience and accelerate crop breeding cycles.

Converge Bio has received a $2.5 million multi-year grant from the Gates Foundation to extend its drug modeling technology into crop genomics, announced in a press release. The funding supports the creation of a multimodal foundation model that identifies genetic variants linked to key agricultural traits such as yield and climate resilience.

The initiative will apply Converge Bio's AI systems, originally built for drug discovery, to analyze crop genomes as large interconnected systems. The approach allows researchers to examine millions of DNA base pairs at once and identify genes or mutations most likely to influence beneficial traits.

The project aims to shorten traditional breeding timelines, which can take more than a decade, by helping scientists and growers pinpoint promising genetic targets earlier in development. The 37-month grant is intended to accelerate the production of crops better adapted to environmental stress and shifting climate conditions.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

06/02
Pathwork Launches Broker Access to Medical and Prescription Data
06/02
Acclinate and HCN Global Partner to Expand Clinical Research Access for Hispanic and Latino Communities
06/02
Cortechs.ai and Microsoft Integrate AI Imaging Tools into Radiology Workflows
06/02
RSC Bay Area Adopts Alife Health AI for Embryo Assessment
06/02
Mount Sinai Deploys Clarium AI Vision to Modernize Surgical Supply Management

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You May Also Like